Control group

 Soriatane -treated group

Villus loss

0.07 ±0.32

2.52 ±0.71*

Villus shortening

0.03 ±0.42

3.40 ±0.70**

Villus fusion

0.06 ±0.32

2.70 ±0.68**

Microvilli damage

0.07 ±0.32

2.50 ± 0.53*

Cellular infiltration

0.10 ±0.12

2.70± 0.80**

*Significant (P < 0.05) high significant **p < 0.01.
L.S. 0: non; 1: scare; 2: moderate; 3: sever; No. of individual = 7
Table 3: Scoring values of the damage in the histopathological analysis of the experimental groups.